Figure 1:
Flowchart shows study participants in group A (treatment-naïve participants with no prior liver-directed and systemic therapies) and group B (participants who experienced hepatic tumor progression following immunoembolization).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.